← Back to Search

Written Exposure Therapy for Suicide Prevention

N/A

Waitlist Available

Led By Brian P Marx, PhD

Research Sponsored by Boston University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline,10 weeks, 20 weeks, 30 weeks

Awards & highlights

Study Summary

This trial will evaluate an evidence-based intervention, WET-SP, to reduce risk of self-injury & rehospitalization for military service members after psychiatric hospitalization.

Who is the study for?

Active duty military service members hospitalized for suicidal thoughts, plans, or attempts and showing significant suicidal ideation. Participants must be able to read, write, and speak English.Check my eligibility

What is being tested?

The trial is testing WET-SP—a brief psychotherapy aimed at reducing distress from suicidal crises—against the usual care (TAU). It involves writing about stressful experiences during hospitalization with follow-ups after discharge.See study design

What are the potential side effects?

As WET-SP is a form of psychotherapy involving writing about personal stressors, side effects may include emotional discomfort or temporary increases in distress.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline,10 weeks, 20 weeks, 30 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline,10 weeks, 20 weeks, 30 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline,10 weeks, 20 weeks, 30 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Suicidal ideation (SI)

SI at 20 weeks

SI at 30 weeks

Secondary outcome measures

Most severe SI

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Written Exposure Therapy-for Suicide Prevention (WET-SP) +TAUExperimental Treatment2 Interventions

Participants randomized into this arm will be offered WET-SP which will consist of 5 treatment sessions, conducted daily while the participant is hospitalized, allowing for the largest dose of treatment possible while inpatient. If a patient is discharged prior to the completion of WET-SP, the remaining sessions will be conducted in outpatient sessions. Participants in this arm will also be offered TAU.

Group II: Treatment as usual (TAU)Active Control1 Intervention

Participants randomized into this arm will be offered TAU which consists of daily contact and patient centered care by the acute psychiatric inpatient unit provider team (e.g., psychiatrists, therapists, case managers, behavioral health techs). Participants will engage with the provider team daily throughout the duration of hospitalization.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

TAU

2016

Completed Phase 3

~8350

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Boston UniversityLead Sponsor

454 Previous Clinical Trials

9,941,410 Total Patients Enrolled

United States Department of DefenseFED

861 Previous Clinical Trials

227,034 Total Patients Enrolled

School of Medicine, Anschutz Medical Campus, Colorado UniversityUNKNOWN

Media Library

Treatment-as-Usual (TAU) Clinical Trial Eligibility Overview. Trial Name: NCT05878795 — N/A

Suicide Attempt Research Study Groups: Treatment as usual (TAU), Written Exposure Therapy-for Suicide Prevention (WET-SP) +TAU

Suicide Attempt Clinical Trial 2023: Treatment-as-Usual (TAU) Highlights & Side Effects. Trial Name: NCT05878795 — N/A

Treatment-as-Usual (TAU) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05878795 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining slots available for enrolment in this investigation?

"According to clinicaltrials.gov, the enrolment period for this medical trial has passed as it was first posted on July 1st 2023 and last updated on May 18th of that year. Nonetheless, 181 alternative studies are actively recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Written Exposure Therapy for Suicide Prevention

2024. "Written Exposure Therapy for Suicide Prevention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05878795.